Evotec rechtsform
WebApr 1, 2024 · Der Pharmakonzern EVOTEC hat seine Rechtsform geändert. Wie das Unternehmen mitteilte, wurde die Umwandlung in eine Europäische … Rechtsform: Societas Europaea: ISIN: DE0005664809: Gründung: 1993 Sitz: Hamburg, Deutschland: Leitung: Werner Lanthaler, Vorstandsvorsitzender Craig Johnstone Cord Dohrmann Laetitia Rouxel; Iris Löw-Friedrich, Aufsichtsratsvorsitzende; Mitarbeiterzahl >4000: Umsatz: 500,9 Mio. Euro (2024) Branche: Biotechnologie … See more Die Evotec SE ist ein international tätiges Unternehmen im Bereich der pharmazeutischen Wirkstoffforschung mit Sitz in Hamburg. In Forschungsallianzen und Entwicklungspartnerschaften mit Pharma- und … See more Evotec ist ein Wissenschaftskonzern, der Medikamente erforscht und entwickelt. Die multimodale Plattform des Unternehmens kombiniert verschiedene Technologien, Daten und wissenschaftliche Ansätze für die Erforschung, Entwicklung und Produktion von first … See more • Bayer (verschiedene Indikationen, u. a. Chronischer Husten, Endometriose, Nierenerkrankungen etc.) • Bristol Myers Squibb (Onkologie und Neurodegenerative Krankheiten) • CHDI (Huntington-Krankheit) See more Vorstand • Werner Lanthaler (Chief Executive Officer) • Enno Spillner (Chief Financial Officer) • Cord Dohrmann (Chief Scientific Officer) See more 1993 wurde das Biotechnologieunternehmen als Evotec BioSystems in Hamburg gegründet. Gründer waren der Nobelpreisträger Manfred Eigen und … See more Evotec hat Standorte weltweit. Deutschland • Hamburg (Hauptsitz) • Göttingen • Halle / Westfalen • Köln See more • Website der Evotec SE See more
Evotec rechtsform
Did you know?
WebEvotec is a global provider of drug discovery and development solutions. By leveraging its state-of-the-art multimodality research platform, Evotec enters into discovery and development alliances and partnerships applying innovative, modality-agnostic methods for the development of new or WebNov 4, 2024 · Their stock opened with $21.75 in its Nov 4, 2024 IPO. Evotec is funded by 10 investors. Bill & Melinda Gates Foundation and European Investment Bank are the most recent investors. Evotec has made 24 investments. Their most recent investment was on Dec 1, 2024, when Carrick Therapeutics raised $60M. Evotec has made 4 diversity …
WebApr 10, 2024 · About EVO. Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, … WebApr 26, 2024 · Ticker: EVO CIK: 1412558 Form Type: 20-F Annual Report Accession Number: 0001104659-22-049929 Submitted to the SEC: Tue Apr 26 2024 6:48:48 AM EST Accepted by the SEC: Tue Apr 26 2024 Period: Friday, December 31, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media SEC.gov
WebJan 26, 2024 · The agreement was facilitated by Johnson & Johnson Innovation. The collaboration leverages Evotec's integrated discovery and development … WebThey continue to build our reputation as a leading player through their creativity, commitment, professionalism and innovative spirit. Approximately 38% of Evotec’s employees have worked for the Company for more than five years. The average age of Evotec’s employees at the end of 2024 was approximately 38.5 years.
WebSeitenthema: "Geschäftsbericht 2024 - der Aargauischen Landwirtschaftlichen Kreditkasse ALK - Aargauische Landwirtschaftliche ...". Erstellt von: Lui-Horst Keßler. Sprache: deutsch.
WebJan 9, 2024 · Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies ... blackstone industrial holdingsWebOct 26, 2024 · 1 Min Read. (Reuters) -German biotech firm Evotec SE said on Tuesday it would seek a valuation of about $9.2 billion in its initial public offering in the United … blackstone indoor grill electricWebEvotec’s Profile, Revenue and Employees. Evotec is a Germany-based drug discovery company that researches and develops pharmaceutical products for the treatment of diseases such as cancer and diabetes. Evotec’s primary competitors include Berkeley Lights, Charles River, Vertex and 12 more. blackstone industrial services canadaWebShare. Evotec SE (Evotec) is a drug discovery alliance and development partnership company. It discovers and develops small molecule drugs spanning various conditions areas such as oncology, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides drug discovery services ... blackstone industrial sherwood parkWebApr 12, 2024 · 0 Wall Street analysts have issued 12-month price targets for Evotec's shares. Their EVT share price forecasts range from €21.00 to €47.00. On average, they predict the company's stock price to reach €32.50 in the next twelve months. This suggests a possible upside of 79.5% from the stock's current price. View analysts price targets for ... blackstone industrial services sherwood parkWebEvotec’s Profile, Revenue and Employees. Evotec is a Germany-based drug discovery company that researches and develops pharmaceutical products for the treatment of … blackstone industrial groupWebOct 28, 2024 · Evotec intends to raise $576 million in gross proceeds from an IPO of its American Depositary Shares representing ordinary shares, offering 22 million ADSs at a reference price of $26.16. blackstone industries ct